🎄🌟 🎉 Wishing our readers a Merry Christmas and a Happy New Year filled with new possibilities! 🎄🌟 🎉
28 August 2012 | Regulatory | By BioSpectrum Bureau
Taiwan approves stem cell supplement by RBC Life Sciences
Stem-Kine helps increase the level of circulating stem cells
Singapore: Taiwan has approved import and sale of Stem-Kine, a stem cell supplement by RBC Life Sciences, in the country. Stem-Kine is marketed in Taiwan under the name SK Plus.
"Stem cells are early-stage cells formed primarily in bone marrow that can develop into any type of cell - heart, brain or other tissues. Stem cells circulate with the blood, congregating in diseased or damaged tissues, where they replace the injured cells with healthy new cells," explained Mr Clinton Howard, CEO of RBC Life Sciences. "They form the body's internal repair and rejuvenation system. Physicians consistently report that a greater number of the body's own adult stem cells results in more effective repair."
Young people have higher levels of stem cells, and usually recover more quickly from injuries or illness. Beginning twenties, stem cell levels begin a constant decline. However, stem cell levels can be increased exercise and healthy nutrition.
"Stem-Kine was developed as optimum nourishment to bone marrow, enabling it to produce more stem cells. In two published studies, Stem-Kine was shown to result in an increase of 50 percent to 100 percent in the subject's level of circulating stem cells over a prolonged period of time," said Mr Howard.